Monday, April 27, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

Half of US health workers not vaccinated

Every day, more Americans become eligible for the COVID-19 vaccine, yet nearly half of all frontline health care workers remain unvaccinated, even though they were given priority access to the first available doses.

Only 52% of all frontline health care workers say they have received even a first dose of a COVID-19 vaccine, according to a new report from the Kaiser Family Foundation and the Washington Post.

That leaves 48% of health care workers on the frontlines of the fight against COVID-19, including doctors, nurses, housekeepers and home health aides, entirely unprotected against and vulnerable to the virus.

Source: Kaiser Family Foundation

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Videos

Policy Shift in Peptide Regulation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!